MAM
RedFM names Sushant Singh Rathure deputy general manager–sales
MUMBAI: RedFM has appointed Sushant Singh Rathure as deputy general manager–sales. Based in Delhi, he will lead special projects in the north, oversee government and PSU accounts, and head the UP cluster.
Rathure, a business growth specialist with nearly two decades in advertising sales and brand partnerships, moves from Music Broadcast Ltd, where he was associate vice-president, running RC Digital Labs and Radicity. He previously held senior roles at Bharat Media Group, Sony Pictures Networks India, Star India, and The Times of India, with a track record in driving revenues, scaling media businesses and launching new formats.
This is Rathure’s second stint at RedFM, where he earlier led sales for the Mumbai station between 2019 and 2022. He credited RedFM’s chief operating officer, Nisha Narayanan, for the opportunity, saying her “faith and leadership” would inspire him to deliver “with greater dedication and passion.”
A seasoned strategist with regional and national exposure, Rathure is known for building alliances, managing P&Ls, and blending creative solutions with sharp media planning. At RedFM, he returns to familiar turf, this time with a wider remit and higher stakes.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
